Antihypertensive medication use during pregnancy in a real-world cohort of patients diagnosed with a hypertensive disorder of pregnancy

Hypertensive disorders of pregnancy (HDP) are rising in prevalence and associated with adverse maternal and infant health outcomes. Current guidelines recommend labetalol, nifedipine, and methyldopa as acceptable first-line agents to treat HDP in outpatient settings. However, the current practice re...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Julian E., Mulrenin, Ian R., Nguyen, Anh B., Loop, Matthew S., Daubert, Melissa A., Urrutia, Rachel, Lee, Craig R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360165/
https://www.ncbi.nlm.nih.gov/pubmed/37485273
http://dx.doi.org/10.3389/fcvm.2023.1225251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360165/
https://www.ncbi.nlm.nih.gov/pubmed/37485273
http://dx.doi.org/10.3389/fcvm.2023.1225251

Ejemplares similares